These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 26362747)

  • 41. Prevention of Infection in the Perioperative Setting in Patients with Rheumatic Disease Treated with Immunosuppression.
    Baker JF; George MD
    Curr Rheumatol Rep; 2019 Mar; 21(5):17. PubMed ID: 30847768
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Long-term use of methotrexate does not result in hepatitis B reactivation in rheumatologic patients.
    Laohapand C; Arromdee E; Tanwandee T
    Hepatol Int; 2015 Apr; 9(2):202-8. PubMed ID: 25788188
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Progressive multifocal leukoencephalopathy associated with immunosuppressive therapy in rheumatic diseases: evolving role of biologic therapies.
    Molloy ES; Calabrese LH
    Arthritis Rheum; 2012 Sep; 64(9):3043-51. PubMed ID: 22422012
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Immunosuppressive medications during pregnancy and lactation in women with autoimmune diseases.
    Elliott AB; Chakravarty EF
    Womens Health (Lond); 2010 May; 6(3):431-40; quiz 441-2. PubMed ID: 20426608
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Rheumatic diseases need more attention in case of the desire to have children and during pregnancy].
    de Man YA; Dolhain RJ; Steegers EA; Hazes JM
    Ned Tijdschr Geneeskd; 2011; 155(13):A2622. PubMed ID: 21447200
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Treatment with immunosuppressive and biologic drugs of pregnant women with systemic rheumatic or autoimmune disease].
    Alijotas-Reig J; Esteve-Valverde E; Ferrer-Oliveras R
    Med Clin (Barc); 2016 Oct; 147(8):352-360. PubMed ID: 27389618
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Role of Viruses in the Pathogenesis of Multiple Sclerosis.
    Tarlinton RE; Martynova E; Rizvanov AA; Khaiboullina S; Verma S
    Viruses; 2020 Jun; 12(6):. PubMed ID: 32545816
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Viral infections in acute graft-versus-host disease: a review of diagnostic and therapeutic approaches.
    Tong LX; Worswick SD
    J Am Acad Dermatol; 2015 Apr; 72(4):696-702. PubMed ID: 25582535
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Safety of Etanercept in the treatment of rheumatic disease patients with Hepatitis C virus infection.
    Teixeira L; Fonseca C; Sousa S; Vinagre F; Cordeiro A; Gonçalves P; Santos MJ; Canas da Silva J
    Acta Reumatol Port; 2018; 43(2):159-160. PubMed ID: 30091962
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Clinical immunotoxicity of antirheumatic drugs.
    Bálint G; Gergely P
    Inflamm Res; 1996 Dec; 45 Suppl 2():S91-5. PubMed ID: 8988409
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Rare viral infections during immunosuppressive therapy: a "normal" side effect?].
    Glück T
    Z Rheumatol; 2011 Jul; 70(5):375-8. PubMed ID: 21267726
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Drugs in pregnancy. Rheumatological disorders.
    Østensen M
    Best Pract Res Clin Obstet Gynaecol; 2001 Dec; 15(6):953-69. PubMed ID: 11800535
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Biological treatment of rheumatic diseases].
    Procházková L; Böhmová J; Soucek M
    Vnitr Lek; 2006 Jun; 52(6):632-9. PubMed ID: 16871769
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Infections during antirheumatic treatment].
    Kneitz C
    Dtsch Med Wochenschr; 2014 Aug; 139(31-32):1593-5. PubMed ID: 25076314
    [No Abstract]   [Full Text] [Related]  

  • 55. Critical review of the current recommendations for the treatment of systemic inflammatory rheumatic diseases during pregnancy and lactation.
    Levy RA; de Jesús GR; de Jesús NR; Klumb EM
    Autoimmun Rev; 2016 Oct; 15(10):955-63. PubMed ID: 27490204
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Hepatitis B and C infection in patients undergoing biologic and targeted therapies for rheumatic diseases.
    Mok CC
    Best Pract Res Clin Rheumatol; 2018 Dec; 32(6):767-780. PubMed ID: 31427054
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Treatment of rheumatic diseases in children: special considerations.
    Milojevic DS; Ilowite NT
    Rheum Dis Clin North Am; 2002 Aug; 28(3):461-82. PubMed ID: 12380365
    [TBL] [Abstract][Full Text] [Related]  

  • 58. No detection of occult HBV-DNA in patients with various rheumatic diseases treated with anti-TNF agents: a two-year prospective study.
    Giardina AR; Ferraro D; Ciccia F; Ferrante A; Di Stefano R; Craxì A; Triolo G
    Clin Exp Rheumatol; 2013; 31(1):25-30. PubMed ID: 22935442
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Perioperative Management of Rheumatic Disease and Therapies.
    Zisa D; Goodman SM
    Rheum Dis Clin North Am; 2022 May; 48(2):455-466. PubMed ID: 35400371
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A practical approach to vaccination of patients with autoimmune inflammatory rheumatic diseases in Australia.
    Wong PKK; Bagga H; Barrett C; Hanrahan P; Johnson D; Katrib A; Leder K; Marabani M; Pentony P; Riordan J; White R; Young L
    Intern Med J; 2017 May; 47(5):491-500. PubMed ID: 28101910
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.